GW 597599

GW 597599 Uses, Dosage, Side Effects, Food Interaction and all others data.

GW 597599, a neurokinin-1 (NK1) receptor antagonist is currently in phase II trials for chemotherapy-induced vomiting; functional dyspepsia; depression and anxiety.

Trade Name GW 597599
Generic GW 597599
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
GW 597599
GW 597599

Uses

Investigated for use/treatment in adverse effects (chemotherapy), anxiety disorders, depression, and gastrointestinal diseases and disorders (miscellaneous).

Innovators Monograph

You find simplified version here GW 597599

*** Taking medicines without doctor's advice can cause long-term problems.
Share